Welcome to our dedicated page for Curaleaf Hldgs news (Ticker: CURLF), a resource for investors and traders seeking the latest updates and insights on Curaleaf Hldgs stock.
Curaleaf Holdings, Inc. reports developments across its consumer cannabis business, including retail dispensary openings, medical and adult-use product brands, quarterly operating results, and international expansion. The company trades on the Toronto Stock Exchange as CURA and on OTCQX as CURLF.
Recurring updates cover brands such as Curaleaf, Select, Grassroots, Find, Dark Heart, Anthem, and Four 20 Pharma; U.S. dispensary activity; medical cannabis distribution in Germany and other international markets; share repurchase activity; board and shareholder matters; and regulatory topics affecting cannabis operations.
Curaleaf Holdings reported strong financial results for Q2 2021, showing revenue of $312 million, a 166% year-over-year increase. Adjusted EBITDA reached $84 million, reflecting a 201% growth compared to the previous year. The gross margin improved to 49.6%, attributed to higher yields and operational efficiencies. Despite a net loss of $7.2 million, down from $17.2 million in Q1, the company completed the acquisition of EMMAC, enhancing its European presence. Curaleaf aims to leverage market opportunities with expanded adult-use markets in the U.S.
Curaleaf Holdings, Inc. (CURA/CURLF), a leading cannabis provider, announced that Executive Chairman Boris Jordan will present at the Canaccord Genuity 41st Annual Growth Conference on August 10, 2021, at 9:00 am ET. The management team will also hold investor meetings during this event. Curaleaf operates in 23 states with 108 dispensaries and is known for its high-quality cannabis products, aiming to enhance consumer confidence.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) has opened its 108th dispensary, located in Wells, Maine, marking its fifth location in the state. The new store will cater to medical cannabis patients, providing high-quality products and services, including curbside pick-up. The location complies with Maine's reciprocity laws, allowing out-of-state patients to access services. To celebrate the opening, Curaleaf is offering discounts and free delivery from July 23-25, as well as donating $5,000 to a local veterans' organization.
Curaleaf launches the B Noble brand to support social equity in cannabis, particularly highlighting the story of Bernard Noble, wrongfully imprisoned for cannabis possession. The brand, founded by Fab 5 Freddy, aims to raise awareness and funding for those impacted by harsh drug laws. It will release pre-roll products in Massachusetts and Maryland, donating 10% of proceeds to local organizations aiding those affected by the War on Drugs. This initiative aligns with Curaleaf's Rooted in Good program, promoting diversity and equity in the cannabis industry.
Curaleaf Holdings (CSE: CURA / OTCQX: CURLF) has appointed Ranjan Kalia as Chief Financial Officer, effective July 19, 2021, succeeding Michael Carlotti, who stepped down for medical reasons. Kalia brings over 30 years of experience in finance from companies like Virtusa Corp and EMC Corporation. Joseph Bayern, CEO, expressed optimism about Kalia's role in fueling the company's growth. Curaleaf operates 107 dispensaries across 23 states and is the largest vertically integrated cannabis company in Europe, underlining its commitment to strong financial performance.
Curaleaf Holdings has announced it will release its financial results for the second quarter ending June 30, 2021, on August 9, 2021, after market close. Management will hold a conference call and audio webcast at 5:00 p.m. ET that same day, featuring key operational highlights. Interested parties can join via phone or through a webcast. Curaleaf is a leading cannabis provider operating in 23 U.S. states and is the largest vertically integrated cannabis company in Europe.
Curaleaf International has formed a strategic partnership with Zambon GmbH, aiming to provide medical cannabis treatments in Germany, particularly for neurological therapies. The initial treatment is set to launch in Summer 2021. This partnership highlights Curaleaf's commitment to integrating pharmaceutical expertise with cannabis research. Germany's medical cannabis market is projected to reach USD 2.1 billion by 2025, making it a significant opportunity for growth. Both companies seek to enhance the quality of life for patients with chronic neurological conditions.
Curaleaf Holdings, Inc. announced the opening of its 107th dispensary in Edgewater Park, New Jersey, marking its second location in the state. The new dispensary will enhance access to cannabis products for medical patients and support the state's growing market. Additionally, Curaleaf's cultivation facility in Winslow is now operational, tripling its cultivation capacity. The company plans to open a third dispensary in Central New Jersey later this summer and is focused on creating jobs and community impact through its initiatives.
Curaleaf Holdings, Inc. (CSE: CURA) (OTCQX: CURLF) will participate in Cantor Fitzgerald's "Weednesday Series" investor fireside chat on June 30, 2021, at 11:00 am ET. Boris Jordan, Executive Chairman, will be featured in the live webcast hosted by Pablo Zuanic, U.S. Consumer and Cannabis Equity Analyst at Cantor Fitzgerald. Curaleaf operates in 23 U.S. states, managing 106 dispensaries, 23 cultivation sites, and over 30 processing sites, employing more than 4,800 staff members. The company emphasizes quality and reliability in its cannabis products and services.
Curaleaf has formed a strategic partnership with Rolling Stone to launch a new line of co-branded cannabis products aimed at enhancing the music experience. The initial offerings will include Select's first pre-roll and 'The Cliq' pod system, available in three strains: 'Overdrive' Sativa, 'Reverb' Indica, and 'Phaser' Hybrid. The products will be distributed through Curaleaf's dispensaries in Nevada. The collaboration aims to create a unique retail space in Las Vegas in 2022, celebrating the intersection of music and cannabis.